Press Releases

Liquidia Technologies Announces $22.4 Million Private Placement

RESEARCH TRIANGLE PARK, N.C. , Dec. 24, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq:LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary PRINT ® technology, today announced that it
Dec 24, 2019

Liquidia to Present at Cantor 2019 Global Healthcare Conference

RESEARCH TRIANGLE PARK, N.C. , Sept. 25, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia” or the “Company”), a late-stage clinical biopharmaceutical company, announced that Neal Fowler , Chief Executive Officer of Liquidia , will present a company overview at the
Sep 25, 2019

Liquidia to Present at H.C. Wainwright Healthcare Conference

RESEARCH TRIANGLE PARK, N.C. , Sept. 03, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia” or the “Company”), a late-stage clinical biopharmaceutical company, announced that Neal Fowler , Chief Executive Officer of Liquidia , will present a company overview at the H.C.
Sep 03, 2019

Liquidia to Present at Wedbush PacGrow Healthcare Conference

RESEARCH TRIANGLE PARK, N.C. , Aug. 08, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia” or the “Company”), a late-stage clinical biopharmaceutical company, announced that Neal Fowler , Chief Executive Officer of Liquidia , will present a company overview at the 2019
Aug 08, 2019
Displaying 51 - 60 of 93